What You Need to Know Before Booking a Ticket
Cell therapy conferences are where academic researchers, biotech founders, regulatory consultants, and CRO reps all pretend to be on the same page. They're not. The 2023 circuit had a lot of overlap between event names, and a lot of the sessions duplicated content from the prior year's meetings with updated slide decks. If you're going in blind, you'll waste money and time. Here's how to actually get value out of it. The major events that year were the ASGCT Annual Meeting, the CAR T Summit, the Regenerative Medicine conference series, and a handful of regional gatherings in Europe and Asia. Most of them ran between March and October, with ASGCT in April being the biggest draw. Registration for ASGCT was around $895 for early birds and jumped to roughly $1,195 at the door. The CAR T Summit was significantly cheaper at about $595, but the attendance was more industry-focused and less academic. Here's something people don't tell you: the real value at these conferences isn't in the keynote speeches. It's in the poster sessions and the hallway conversations. I've seen PhD students land postdoc positions and startup founders close their first CRO contracts at posters. The stages are mostly marketing. The hallways are where the actual work happens.
I learned this the hard way in 2023. I went to ASGCT expecting to catch up on regulatory updates from the FDA and EMA panels. Instead, I spent most of my time at a poster about manufacturing scalability for autologous CAR-T products. The presenter was a process engineer from a mid-size CRO who'd figured out a workaround for cryopreservation variability that cut thaw recovery from 68 percent to 84 percent. That poster changed how we run our own GMP batches. The keynote that same morning was about something completely generic. Don't optimize your schedule for the stages. Optimize it for the rooms with the least seating.
How to Actually Navigate These Events
Download the event app before you arrive. Most conferences have them now, and they let you build a personalized schedule. The problem is the apps are usually buggy. At the 2023 CAR T Summit, the app crashed twice during the first day and the speaker changes weren't updated in real time. I ended up using a shared Google Sheet with my colleagues, color-coded by track and building. It took ten minutes to set up and saved me from missing three sessions I'd specifically wanted to attend. Print the program. Yes, print it. Some of the smaller venues had unreliable Wi-Fi, and the large halls had poor cellular reception because everyone was standing around with their phones trying to check schedules. A physical copy cost me nothing and avoided about forty-five minutes of frustration over two days. Bring business cards. I know, it feels archaic. But the people you need to talk to at these events don't check LinkedIn. They check the card you hand them and maybe look you up later that evening. I've lost count of how many times someone asked for my card during a poster discussion and then never followed up because I'd written my email on the back wrong. Always double-check what you wrote.
Get the Full Details
What to Expect From the Content
The scientific content at cell therapy conferences in 2023 was heavily skewed toward CAR-T and NK cell therapies. Gene editing and MSC-based approaches had smaller tracks. The regulatory sessions were useful but repetitive. If you attended the FDA workshop on IND submissions for autologous products at one conference, you'd hear essentially the same talking points at the next three. The agency wasn't changing its position mid-year. Manufacturing and scale-up was the dominant practical concern. Every track had at least one session on GMP compliance, process validation, or cost of goods. This makes sense. The science is advancing faster than the manufacturing infrastructure can keep up with. Nobody at these conferences has a clean answer for how to make autologous therapies affordable at scale. They know they don't have it yet. One counter-intuitive thing: the most useful sessions were often the ones labeled as "industry perspective" or "regulatory update." The basic science talks were frequently behind the published literature by eighteen to twenty-four months. If you need to know what's cutting edge, read the journals. If you need to know what's going to get approved next year, sit through the regulatory track.
Pitfalls to Avoid
Social events are expensive. The conference receptions, sponsor dinners, and optional excursions add up fast. A single sponsor dinner at ASGCT ran about $75 per person. The networking is real, but so is the markup. Set a budget before you go and stick to it. I've watched people blow their entire travel budget on optional events and then skip the sessions they actually wanted because they couldn't afford to stay an extra night. Don't try to see everything. The default assumption at these conferences is that you'll maximize every hour. You won't. You'll get exhausted, you'll miss the conversations that matter, and you'll end up scrolling through your phone in the back of sessions you dragged yourself to. Pick three tracks and commit to them. The rest is noise. Another thing nobody mentions: the exhibitor hall is largely sales pitches. The companies showcasing there are real, but their demos are polished. I sat through a vendor presentation for a closed-system bioreactor that looked impressive on paper. The rep couldn't tell me what the actual kill rate was for Mycoplasma during processing. That's your filter. If an exhibitor can't answer a specific technical question on the spot, move on.
Which Conferences Are Worth It
ASGCT remains the most comprehensive event for the field. It covers gene therapy and cell therapy, spans regulatory and manufacturing, and draws the largest academic and industry mix. If you can only attend one, this is it. The tradeoff is the size and the cost. The CAR T Summit is the best focused alternative. It's smaller, cheaper, and deeper on the specific modality. If your work is in that lane, skip ASGCT and go here instead. You'll see more relevant science and spend less time walking between venues. For European attendees, the EURIMA conference and the Society for Gene & Cell Therapy meetings are solid. They run in the fall and tend to have stronger regulatory participation from the EMA side. The content quality is comparable to the US events. Travel costs vary depending on your location.
/
